Sergi Ferre
Overview
Explore the profile of Sergi Ferre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
7100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsoukas M, Ciruela-Jardi M, Gallo M, Ferre S, Andreu D, Casado V, et al.
J Med Chem
. 2024 Dec;
68(1):261-269.
PMID: 39726149
Activation of cannabinoid CB receptors (CBR) by agonists induces analgesia but also induces cognitive impairment through the heteromer formed between CBR and the serotonin 5HT receptor (5HTR). This side effect...
2.
Levinstein M, De Oliveira P, Casajuana-Martin N, Quiroz C, Budinich R, Rais R, et al.
Mol Psychiatry
. 2024 Dec;
PMID: 39639176
No abstract available.
3.
Lujan R, Martin-Belmonte A, Ferre S, Ciruela F
Neural Regen Res
. 2024 Jul;
20(5):1409-1410.
PMID: 39075907
No abstract available.
4.
Alachkar A, Phan A, Dabbous T, Alhassen S, Alhassen W, Reynolds B, et al.
J Neurosci Res
. 2024 Feb;
102(2):e25299.
PMID: 38361407
The dopamine D receptor 7-repeat allele (D R) has been linked with psychiatric disorders such as attention-deficit-hyperactivity disorder, autism, and schizophrenia. However, the highly diverse study populations and often contradictory...
5.
Levinstein M, De Oliveira P, Casajuana-Martin N, Quiroz C, Budinich R, Rais R, et al.
Mol Psychiatry
. 2023 Dec;
29(3):624-632.
PMID: 38145984
(R,S)-methadone ((R,S)-MTD) is a µ-opioid receptor (MOR) agonist comprised of (R)-MTD and (S)-MTD enantiomers. (S)-MTD is being developed as an antidepressant and is considered an N-methyl-D-aspartate receptor (NMDAR) antagonist. We...
6.
Ferre S, Winkelman J, Garcia-Borreguero D, Belcher A, Chang J, Earley C
Sleep
. 2023 Oct;
47(3).
PMID: 37864837
Restlessness is a core symptom underlying restless legs syndrome (RLS), neuroleptic-induced akathisia, and opioid withdrawal. These three conditions also share other clinical components suggesting some overlap in their pathophysiology. Recent...
7.
Homar-Ruano P, Cai N, Casado-Anguera V, Casado V, Ferre S, Moreno E, et al.
Mol Neurobiol
. 2023 Jul;
60(11):6566-6583.
PMID: 37464153
The functional role of the dopamine D receptor (DR) and its main polymorphic variants has become more evident with the demonstration of heteromers of DR that control the function of...
8.
Ferre S, Kofalvi A, Ciruela F, Justinova Z, Pistis M
Trends Pharmacol Sci
. 2023 Jun;
44(8):495-506.
PMID: 37331914
It is generally assumed that the rewarding effects of cannabinoids are mediated by cannabinoid CB receptors (CBRs) the activation of which disinhibits dopaminergic neurons in the ventral tegmental area (VTA)....
9.
Ferre S, Pardo L, Ciruela F
Neural Regen Res
. 2023 Apr;
18(10):2204-2205.
PMID: 37056138
No abstract available.
10.
Michaelides M, Levinstein M, De Oliveira P, Casajuana-Martin N, Quiroz C, Budinich R, et al.
Res Sq
. 2023 Mar;
PMID: 36993715
(R,S)-methadone ((R,S)-MTD) is a racemic μ-opioid receptor (MOR) agonist comprised of (R)-MTD and (S)-MTD enantiomers used for the treatment of opioid use disorder (OUD) and pain. (R)-MTD is used as...